Presentation TCT 2016 TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study Presenter: Lutz Buellesfeld, Raj Makkar, Jeffrey J. Popma October 31, 2016
Presentation TCT 2016 Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR Presenter: Dmitriy N. Feldman, Rahul Sakhuja October 31, 2016
News Conference News TCT 2016 Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field? Todd Neale October 30, 2016
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure) Presenter: A. Pieter Kappetein, Allan Schwartz, Samir R. Kapadia October 30, 2016
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr. October 30, 2016
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip) Presenter: A. Pieter Kappetein, Allan Schwartz, Marco Barbanti October 30, 2016
Presentation TCT 2016 Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial Presenter: A. Pieter Kappetein, Allan Schwartz, Martin B. Leon October 30, 2016
Presentation TCT 2016 Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It? Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Antonio Enrique Dager October 30, 2016
Presentation TCT 2016 Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR Presenter: A. Pieter Kappetein, Allan Schwartz, Howard C. Herrmann October 30, 2016
Presentation TCT 2016 TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Chris Meduri October 30, 2016
Presentation TCT 2016 Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis Presenter: A. Pieter Kappetein, Allan Schwartz, Philippe Pibarot October 30, 2016
Presentation TCT 2016 TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples) Presenter: A. Pieter Kappetein, Allan Schwartz, Mathew Williams October 30, 2016
Presentation TCT 2016 Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure? Presenter: Dariusz Dudek, Petr Kala, Michael Haude October 30, 2016
Presentation TCT 2016 Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure? Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala October 30, 2016
Presentation TCT 2016 Integration of the Extended Heart Team for Clinical Decision-Making in Patients With Aortic Stenosis Presenter: Marian C. Hawkey, Amanda M Kirby October 30, 2016
Presentation TCT 2016 France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure? Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent October 30, 2016
Presentation TCT 2016 Hemodynamics of Aortic Stenosis: You CAN Do This Presenter: Thomas H. Maloney, Jeff Davis October 29, 2016
News Daily News FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy L.A. McKeown October 27, 2016
News Daily News Las Mujeres Embarazadas con Estenosis Aórtica Casi Siempre Sobreviven Pero con Complicaciones October 11, 2016